CIM
SION

Contravisory Investment Management’s Sionna Therapeutics SION Stock Holding History

Contravisory Investment Management’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264 Buy
+6
New +$240 ﹤0.01% 377

Other funds holding SION

GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Contravisory Investment Management's SION Position: Q2 2026 in Review

Contravisory Investment Management opened a new position in Sionna Therapeutics (SION) in Q2 2026: 6 shares worth $264. The stake represents ﹤0.01% of the portfolio and ranks #377 among its holdings.

5 funds tracked by Wall St. Rank hold SION as of Q2 2026.

  • Contravisory Investment Management held 6 shares of Sionna Therapeutics worth $264 as of Q2 2026.
  • Sionna Therapeutics was a new Contravisory Investment Management position in Q2 2026.
  • Sionna Therapeutics made up ﹤0.01% of Contravisory Investment Management's portfolio in Q2 2026, its #377 holding.
  • 5 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.